Episode
Biogen Enters GA Treatment Market After Major Acquisition
- Podcast
- Eyewire News: The Podcast
- Published
- Apr 1, 2026
- Duration seconds
- 344
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/BMCL4543424209.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/biogen-enters-ga-treatment-market-after-major-acquisition/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/biogen-enters-ga-treatment-market-after-major-acquisition.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices